Sacubitril/valsartan eligibility and outcomes in the ESC...

  • Main
  • 2019 / 05
  • Sacubitril/valsartan eligibility and outcomes in the ESC...

Sacubitril/valsartan eligibility and outcomes in the ESC HFA EORP Heart Failure Long‐Term Registry: bridging between EMA/FDA label, the PARADIGM‐HF trial, ESC Guidelines, and real‐world

Kapelios, Chris J., Lainscak, Mitja, Savarese, Gianluigi, Laroche, Cécile, Seferovic, Petar, Ruschitzka, Frank, Coats, Andrew, Anker, Stefan D., Crespo‐Leiro, Maria G., Filippatos, Gerasimos, Piepoli,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
European Journal of Heart Failure
DOI:
10.1002/ejhf.1532
Date:
May, 2019
File:
PDF, 2.05 MB
2019
Conversion to is in progress
Conversion to is failed